Forget the treat for cancer, heart disease, Alzheimer, or diabetes. Unless …
If you would like a cure for cancer, heart disease, Alzheimer, or diabetes, don’t count on the academia, the National Institute of Health (NIH), or the biotech/pharmaceutical industry. With all the cash they need spent on researching these diseases, they need terribly very little to indicate for it.
In 1971, during the State of the Union address, President Nixon declared the war on cancer proposing “an intensive campaign to seek out a cure for cancer.” Since 1971, Americans spent, through taxes, donations, and private R&D, about $200 billion in inflation-adjusted dollars. This money made 1.fifty six million papers on cancer. However, these days we have a tendency to are no nearer to a cure than we have a tendency to were in 1971. Why?
Take into account what Dr. Almog said in his paper: Drug Business in “depression” (Almog, D. Drug industry in “depression”. Med Sci Monit. 2005 Jan;11(1):SR1-4, I would urge you to browse his paper, it’s an eye fixed opener on relationship between educational research and commercial drug discovery): “When the basic science/biology of disease isn’t on the market, no new medicine return to market.” With the billion of greenbacks spent by the NIH on basic science, and also the a lot of papers printed on the subject, the question is, “Why isn’t the essential science/biology of disease available? Individual discoveries within the biology of human disease are cornerstone in new treatments. But, in drug discovery, these basic science/biology discoveries are seemingly unrelated dots. To attach the dots you would like a theory. The Blind Men and also the Elephant may be a famous story regarding six blind men encountering an elephant for the primary time. Every man, seizing on the single feature of the animal, which he appeared to own touched first, and being incapable of seeing it whole, loudly maintained his limited opinion on the character of the beast. The elephant was thought-about a wall, a spear, a snake, a tree, a lover or a rope, depending on whether or not the blind men had initial grasped the creature’s aspect, tusk, trunk, knee, ear or tail. The story epitomizes the matter of the reductionist approach in biology. A recent book Microcompetition with Foreign DNA and also the Origin of Chronic Disease, by Hanan Polansky [11], presents an alternative. The book identifies the disruption that causes atherosclerosis, cancer, obesity, osteoarthritis, kind II diabetes, alopecia, kind I diabetes, multiple sclerosis, asthma, lupus, thyroiditis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, atopic dermatitis, graft versus host disease, and different chronic diseases, and describes the sequence of events that leads from the disruption to the molecular, cellular, and clinical effects.”
What are the implications of the NIH failure? A decline in the quantity of new medicine introduced by pharmaceutical companies. Contemplate what professor Taylor says in his paper: Fewer new medicine from the pharmaceutical business (Taylor D. Fewer new medication from the pharmaceutical industry. BMJ. 2003 Feb 22;326(7386):408-9): “In 2002 spending on medicines exceeded $400bn (£248bn; 377bn) worldwide. Optimists within the pharmaceutical business believe that the worldwide market for their products will persist expanding by around 10% a year, with the United States continuing to steer towards higher per capita outlays. Expenditure on research by the pharmaceutical business is also increasing worldwide. It’s now over $45bn a year—twice the sum recorded at the beginning of the 1990s—and projected to rise to $55bn by 2005-6. Considerations are growing, but, about the productivity of research being funded by the most important pharmaceutical companies. … Empirical evidence indicates a crisis in productivity in pharmaceutical research. The quantity of medicines introduced worldwide that contain new active ingredients dropped from a median of over 60 a year in the late 1980s to 52 in 1991 and only 31 in 2001. The general number of new active substances undergoing regulatory review is still falling.”
On the one hand, the expenditure on research is increasing. On the opposite, the quantity of recent drugs is decreasing. The professionals call this situation the productivity crisis in drug discovery.
The NIH failed to supply the therefore much required biology of chronic disease because it’s caught within the reductionist mentality. Dr. Hanan Polansky offers an alternative. If we have a tendency to want a cure for cancer, heart disease, Alzheimer, or diabetes, we need to significantly take into account his alternative.
Popularity: 6% [?]
Related posts:
- Diabetes, Heart Disease, and Stroke Could Happen To You Did you recognize that if you have got diabetes you have got a bigger likelihood of dying from heart disease or stroke and it doesn’t...
- More Aware Of Diabetes-Heart Disease Link With diabetes on the increase, doctors are extraordinarily concerned concerning associated risks like heart disease and stroke, which along kill two out of three individuals...
- Type 2 Diabetes – An Increased Risk For Heart Disease In Canada If you have either form of diabetes, you are at a greater risk for heart disease or suffering from a stroke. Diabetics are more than...
- The Drug Used In The Treatment Of Kind 2 Diabetes Can Help Forestall Cancer! For Sort 2 diabetics the chance of pancreatic, liver, colon, breast, uterine and bladder most cancers is greater than in non diabetics. The good news...
- Few Natural Treatments To Treat Type Two Diabetes Diabetes Type two is one of the most plentiful health problem in today’s times. The majority of the people are sure that medicines are the...